BIOMAT Database Logo BIOMAT Database Logo

A nontoxic chimeric cholera toxin analog. 1996

M Boesman-Finkelstein, and J W Peterson, and L S Thai, and R A Finkelstein
Department of Molecular Microbiology and Immunology, University of Missouri School of Medicine, Columbia 65212, USA.

UI MeSH Term Description Entries
D011993 Recombinant Fusion Proteins Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes. Fusion Proteins, Recombinant,Recombinant Chimeric Protein,Recombinant Fusion Protein,Recombinant Hybrid Protein,Chimeric Proteins, Recombinant,Hybrid Proteins, Recombinant,Recombinant Chimeric Proteins,Recombinant Hybrid Proteins,Chimeric Protein, Recombinant,Fusion Protein, Recombinant,Hybrid Protein, Recombinant,Protein, Recombinant Chimeric,Protein, Recombinant Fusion,Protein, Recombinant Hybrid,Proteins, Recombinant Chimeric,Proteins, Recombinant Fusion,Proteins, Recombinant Hybrid
D002772 Cholera Toxin An ENTEROTOXIN from VIBRIO CHOLERAE. It consists of two major protomers, the heavy (H) or A subunit and the B protomer which consists of 5 light (L) or B subunits. The catalytic A subunit is proteolytically cleaved into fragments A1 and A2. The A1 fragment is a MONO(ADP-RIBOSE) TRANSFERASE. The B protomer binds cholera toxin to intestinal epithelial cells and facilitates the uptake of the A1 fragment. The A1 catalyzed transfer of ADP-RIBOSE to the alpha subunits of heterotrimeric G PROTEINS activates the production of CYCLIC AMP. Increased levels of cyclic AMP are thought to modulate release of fluid and electrolytes from intestinal crypt cells. Cholera Toxin A,Cholera Toxin B,Cholera Toxin Protomer A,Cholera Toxin Protomer B,Cholera Toxin Subunit A,Cholera Toxin Subunit B,Choleragen,Choleragenoid,Cholera Enterotoxin CT,Cholera Exotoxin,Cholera Toxin A Subunit,Cholera Toxin B Subunit,Procholeragenoid,Enterotoxin CT, Cholera,Exotoxin, Cholera,Toxin A, Cholera,Toxin B, Cholera,Toxin, Cholera
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

M Boesman-Finkelstein, and J W Peterson, and L S Thai, and R A Finkelstein
A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity.
May 1997, Proceedings of the National Academy of Sciences of the United States of America,
M Boesman-Finkelstein, and J W Peterson, and L S Thai, and R A Finkelstein
Primary structure of cholera toxin beta-chain: a glycoprotein hormone analog?
January 1977, Science (New York, N.Y.),
M Boesman-Finkelstein, and J W Peterson, and L S Thai, and R A Finkelstein
Mucosal immunization with a genetically engineered pertussis toxin S1 fragment-cholera toxin subunit B chimeric protein.
April 2003, Infection and immunity,
M Boesman-Finkelstein, and J W Peterson, and L S Thai, and R A Finkelstein
Design, synthesis, and evaluation of bisubstrate analog inhibitors of cholera toxin.
July 2008, Bioorganic & medicinal chemistry letters,
M Boesman-Finkelstein, and J W Peterson, and L S Thai, and R A Finkelstein
Construction of nontoxic derivatives of cholera toxin and characterization of the immunological response against the A subunit.
June 1995, Infection and immunity,
M Boesman-Finkelstein, and J W Peterson, and L S Thai, and R A Finkelstein
Identification and characterization of intestinal antigen-presenting cells involved in uptake and processing of a nontoxic recombinant chimeric mucosal immunogen based on cholera toxin using imaging flow cytometry.
January 2014, Clinical and vaccine immunology : CVI,
M Boesman-Finkelstein, and J W Peterson, and L S Thai, and R A Finkelstein
Direct effects on antigen-presenting cells and T lymphocytes explain the adjuvanticity of a nontoxic cholera toxin mutant.
June 1999, Journal of immunology (Baltimore, Md. : 1950),
M Boesman-Finkelstein, and J W Peterson, and L S Thai, and R A Finkelstein
Novel immunostimulatory agent based on CpG oligodeoxynucleotide linked to the nontoxic B subunit of cholera toxin.
April 2006, Journal of immunology (Baltimore, Md. : 1950),
M Boesman-Finkelstein, and J W Peterson, and L S Thai, and R A Finkelstein
Purification and characterization of a novel cell-penetrating carrier similar to cholera toxin chimeric protein.
January 2017, Protein expression and purification,
M Boesman-Finkelstein, and J W Peterson, and L S Thai, and R A Finkelstein
A new cholera toxin.
June 1983, Lancet (London, England),
Copied contents to your clipboard!